Residency · Residency · Family Medicine
Urinary Incontinence in Older Adults
Introduction
Urinary incontinence (UI) affects approximately 50% of older women and 25% of older men, yet fewer than half of affected individuals discuss it with their physician. UI significantly impacts quality of life, contributes to social isolation, depression, falls, and skin breakdown, and is a leading reason for nursing home placement. Family physicians should routinely screen for and manage this common condition.
Classification
| Type | Mechanism | Key Features | Common Causes |
|---|---|---|---|
| Stress (SUI) | Pelvic floor/sphincter weakness | Leakage with cough, sneeze, exercise | Vaginal delivery, obesity, post-prostatectomy |
| Urgency (UUI) | Detrusor overactivity | Sudden urge followed by leakage | Idiopathic, neurologic (stroke, Parkinson) |
| Mixed | Combined stress + urgency | Both triggers present | Common in older women |
| Overflow | Incomplete emptying/retention | Dribbling, weak stream, hesitancy | BPH, diabetic neuropathy, anticholinergics |
| Functional | Mobility/cognition barriers | Unable to reach toilet in time | Dementia, arthritis, institutional setting |
Stress Urinary Incontinence (SUI)
Stress urinary incontinence involves involuntary leakage with increased abdominal pressure from coughing, sneezing, laughing, or exercise. It is caused by weakness of the pelvic floor muscles and urethral sphincter. SUI is more common in women, with risk factors including vaginal delivery, obesity, and estrogen deficiency. In men, it most commonly occurs after prostatectomy.
Urgency Urinary Incontinence (UUI)
Urgency urinary incontinence involves involuntary leakage accompanied by or immediately preceded by a sudden, compelling urge to void. It is associated with overactive bladder (OAB) and detrusor overactivity and is the most common type of incontinence in older adults of both sexes. UUI may be idiopathic or secondary to neurological conditions such as stroke, Parkinson disease, or multiple sclerosis.
Mixed Urinary Incontinence
Mixed urinary incontinence combines stress and urgency components. It is very common in older women, and treatment targets the predominant symptom.
Overflow Incontinence
Overflow incontinence results from incomplete bladder emptying and urinary retention. Causes include benign prostatic hyperplasia, diabetic neuropathy, anticholinergic medications, and fecal impaction. Patients present with dribbling, weak stream, hesitancy, and a sensation of incomplete emptying.
Functional Incontinence
Functional incontinence occurs due to impaired mobility, cognition, or environmental barriers rather than lower urinary tract pathology. It is common in patients with dementia, arthritis, or those in institutional settings with limited bathroom access.
Assessment
History
The 3 Incontinence Questions (3IQ) tool helps classify the type of incontinence. The assessment should evaluate frequency, volume, triggers, pad use, and impact on daily life. The DIAPPERS mnemonic is useful for identifying transient causes: Delirium, Infection (UTI), Atrophic vaginitis, Pharmaceuticals (diuretics, anticholinergics, alpha-blockers, sedatives), Psychological factors (depression), Excessive urine output (from hyperglycemia, heart failure, or excessive fluid intake), Restricted mobility, and Stool impaction. A 48- to 72-hour bladder diary recording voiding times, volumes, leakage episodes, and fluid intake provides objective data to guide management.
Physical Examination
The abdominal exam should evaluate for a palpable bladder, which suggests urinary retention. In women, a pelvic exam assesses for pelvic organ prolapse (cystocele, rectocele), vaginal atrophy, and pelvic floor tone. A digital rectal exam evaluates prostate size in men and rectal tone and fecal impaction in both sexes. The neurological exam should assess sacral nerve function (S2 through S4), perineal sensation, and the bulbocavernosus reflex. A cough stress test, performed by having the patient cough with a full bladder while observing for leakage, helps confirm stress incontinence.
Diagnostic Studies
Urinalysis rules out UTI, hematuria, and glycosuria. A post-void residual (PVR) measurement by bladder scan or catheterization is important, as a PVR greater than 200 mL suggests overflow incontinence. Renal function should be assessed if obstruction or retention is suspected. Urodynamic testing is reserved for complex, refractory, or pre-surgical cases. Cystoscopy is indicated when hematuria, recurrent UTI, or structural pathology is suspected.
Management: Non-Pharmacologic (First-Line)
Behavioral Interventions
Pelvic floor muscle training (Kegel exercises) is first-line for SUI and mixed incontinence. The regimen involves three sets of 10 contractions daily, with benefits typically seen at 6 to 12 weeks. Referral to pelvic floor physical therapy improves adherence and outcomes. Bladder training, which involves scheduled voiding with gradual increases in voiding intervals by 15 to 30 minutes per week, is first-line for UUI. Prompted voiding is a caregiver-dependent approach appropriate for cognitively impaired patients in institutional settings. Timed voiding on a fixed schedule of every 2 to 3 hours is used for patients unable to participate in bladder training.
Lifestyle Modifications
Weight loss of 5 to 10% of body weight decreases SUI episodes by approximately 50%. Reducing caffeine and alcohol intake, managing fluid intake to avoid both excessive and insufficient consumption, treating chronic cough and constipation, and optimizing glycemic control in diabetes all contribute to improvement.
Containment and Skin Care
Absorbent pads and protective garments provide ongoing management for persistent symptoms. Barrier creams help prevent incontinence-associated dermatitis. Indwelling catheters should be avoided and used only when medically necessary.
Management: Pharmacotherapy
For Urgency Incontinence and Overactive Bladder
Antimuscarinics
Available agents include oxybutynin (in immediate-release, extended-release, topical gel, and patch formulations), tolterodine, solifenacin, darifenacin, and fesoterodine. These medications reduce urgency and frequency, with modest efficacy of approximately one to two fewer incontinence episodes per day compared to placebo. They should be avoided in older adults when possible because of anticholinergic side effects including dry mouth, constipation, blurred vision, cognitive impairment, and delirium. When antimuscarinics are necessary, extended-release formulations and agents with lower CNS penetration such as darifenacin and trospium are preferred.
Beta-3 Agonists
Mirabegron (25 to 50 mg daily) and vibegron (75 mg daily) are preferred over antimuscarinics in older adults due to their favorable side effect profile without anticholinergic burden. Blood pressure should be monitored with mirabegron, as it may cause a slight increase. These agents can be combined with low-dose antimuscarinics for refractory cases.
For Stress Incontinence
Topical vaginal estrogen improves urethral mucosal coaptation and is effective for SUI associated with vaginal atrophy. Duloxetine, an SNRI that increases urethral sphincter tone, is used off-label in the United States but is limited by side effects. Overall, pharmacotherapy for SUI is generally less effective than pelvic floor training or surgery.
For Overflow Incontinence
Alpha-blockers such as tamsulosin and alfuzosin are used for BPH-related retention. 5-alpha-reductase inhibitors including finasteride and dutasteride address enlarged prostate. Medications contributing to retention should be discontinued.
Surgical and Procedural Options
The midurethral sling is the gold standard for SUI refractory to conservative measures. Periurethral bulking agent injection offers an alternative for SUI in patients who are poor surgical candidates. Intravesical injection of botulinum toxin A (onabotulinumtoxinA) is effective for refractory OAB but carries a risk of urinary retention. Sacral neuromodulation (InterStim) and percutaneous tibial nerve stimulation (PTNS) provide neuromodulatory options for refractory UUI.
Key Clinical Pearls
Always screen for urinary incontinence because patients are often embarrassed and will not volunteer symptoms unless asked directly. Reversible causes identified through the DIAPPERS mnemonic should be addressed before initiating long-term therapy. Pelvic floor muscle training is the most effective non-surgical treatment for stress incontinence and should be offered to every appropriate patient. Antimuscarinics should be avoided in older adults with cognitive impairment or high anticholinergic burden, with beta-3 agonists serving as safer alternatives. Weight loss is one of the most effective and underutilized interventions for stress urinary incontinence.
References
- Lukacz ES, Santiago-Lastra Y, Albo ME, Brubaker L. Urinary incontinence in women: a review. JAMA. 2017;318(16):1592-1604.
- Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the ACP. Ann Intern Med. 2014;161(6):429-440.
- Gibson W, Wagg A. Incontinence in the elderly, 'normal' ageing, or unaddressed pathology? Nat Rev Urol. 2014;11(10):563-572.
- Gormley EA, Lightner DJ, Burgio KL, et al. AUA/SUFU guideline: diagnosis and treatment of overactive bladder in adults. J Urol. 2019;202(3):558-563.